However, the diagnostic role of RCAN2 for NAFLD still needs to be verified in large-scale prospective studies in the future, especially in other ethnic groups and in NAFLD patients diagnosed by liver biopsy. The gene discussed is RCAN2; the disease is metabolic dysfunction-associated steatotic liver disease.